Skip to main content
. 2018 Apr 10;9(27):19368–19378. doi: 10.18632/oncotarget.25053

Table 2. Comparison of allele frequencies of EGFR mutations in cfDNA samples of NSCLC patients as determined by digital PCR and targeted sequencing.

Case No EGFR mutation Allele frequency in pre-RT by digital PCR (copy/mL) Allele frequency during RT by digital PCR (copy/mL) Allele frequency in pre-RT by targeted sequencing Allele frequency during RT by targeted sequencing
case 1 - - - N.D. 7.8% (G719C)
case 2 L858R N.D (0) 0.9% (10562) N.D. 0.5%
case 12 exon 19 del. 0.2% (20866) 0.4% (139579) N.D. N.D.
case 15 L858R 44194 (0·5%) 2.3%(363269) 0.3% 1.5%
T790M N.D. (0) 0.4% (40824) N.D. 0.3%
case 16 L858R (N.D.) 0·2% N.D. 2.8%
L747S - - N.D. 2.3%
case 17 exon 19 del. N.D. (64282) 6.4% (2122718) 0.3% 7.3%

Note: del., deletion; N.D., not determined; RT, radiotherapy.